Retail sale of other food
PROVECTUS PHARMA NORDIC AS
Revenue 2024
NOK 20.2m
Operating profit
NOK 386,000
Equity
NOK 2.2m
Incorporated
2021
Share capital
NOK 120,000
Key figures · 2024
Current ratio
1.29
Equity ratio
23.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 1.9% | |
| Net margin (%%) | 1.2% | |
| Return on assets (%%) | 4.2% | |
| Likviditet | ||
| Current ratio | 1.29 | |
| Working capital | 2.0m | |
| Soliditet | ||
| Equity ratio (%%) | 23.5% | |
| Debt-to-equity ratio | 3.25 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.